KENNETH I. MOCH

Insider Reports History

Location
Larchmont, NY
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by KENNETH I. MOCH:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gamida Cell Ltd. Director Ordinary Shares 232,300 31 Jan 2024 Direct
Gamida Cell Ltd. Director Share Option (Right to Buy) 56,600 19 Oct 2023 Direct
Zynerba Pharmaceuticals, Inc. Director Common Stock 0 $1.33 10 Oct 2023 Direct
Zynerba Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 10 Oct 2023 Direct

Insider Reports Filed by KENNETH I. MOCH

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588924002346-moch-kenneth-i-2024-01-31 Gamida Cell Ltd. 31 Jan 2024 1 $0 4 Director 02 Feb 2024, 16:55
/report/000120919123053260-moch-kenneth-i-2023-10-19-restatement Gamida Cell Ltd. 19 Oct 2023 2 $0 4/A Director 20 Oct 2023, 16:33
/report/000114036123047725-moch-kenneth-i-2023-10-10 Zynerba Pharmaceuticals, Inc. 10 Oct 2023 4 $0 4 Director 11 Oct 2023, 09:58
/report/000106299323013667-moch-kenneth-i-2023-06-13 Zynerba Pharmaceuticals, Inc. 13 Jun 2023 3 -$40.03 4 Director 15 Jun 2023, 16:30
/report/000120919123008548-moch-kenneth-i-2023-02-08 Gamida Cell Ltd. 08 Feb 2023 2 $0 4 Director 10 Feb 2023, 18:28
/report/000120919122058393-moch-kenneth-i-2022-11-18 Gamida Cell Ltd. 18 Nov 2022 2 $0 4 Director 22 Nov 2022, 15:36
/report/000106299322015039-moch-kenneth-i-2022-06-14 Zynerba Pharmaceuticals, Inc. 14 Jun 2022 3 -$40.4 4 Director 16 Jun 2022, 21:50
/report/000120919122000155-moch-kenneth-i-2022-01-01 Gamida Cell Ltd. 01 Jan 2022 0 $0 3 Director 03 Jan 2022, 15:20
/report/000119248221000642-moch-kenneth-i-2021-08-03 Zynerba Pharmaceuticals, Inc. 03 Aug 2021 2 $0 4 Director 05 Aug 2021, 17:21